NCT01201044

Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC)

A Randomized, Two Arm Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC)

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: Third Military Medical University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to investigate the efficacy of BAI Plus 3DCRT in local advanced NSCLC.

Conditions

• Non-small Cell Lung Cancer

Interventions

Type	Name	Description
DRUG	Gemcitabine, Nedaplatin, iV	Gemcitabine, Injection, 1000mg/m2, D1 \& D7/ 4weeks/cycle, 2 cycles Nedaplatin, Injection, 75mg/m2, d1/4weeks/cycle, 2 cycles.
RADIATION	3DCRT	non-PD Patient will be treated with 3DCRT after 2 cycles of chemo.
RADIATION	3DCRT	non-PD Patient will be treated with 3DCRT after 2 cycles of chemo.
DRUG	Gemcitabine，Nedaplatin, BAI	Drug: Gemcitabine, Nedaplatin, iV Gemcitabine, Injection, 1000mg/m2, D1/4weeks/cycle, 2 cycles Nedaplatin, Injection, 75mg/m2, d1/4weeks/cycle, 2 cycles. BAI

Timeline

• Start date: 2010-01-01
• Primary completion: 2012-09-01
• Completion: 2012-12-01
• First posted: 2010-09-14
• Last updated: 2010-09-14

Locations

1 site across 1 country: China